RadConnect Communication Application (RadConnect)

The aim is to evaluate the impact of an innovative asynchronous communication application on the number of calls from technologists to radiologists. Even though it is paramount that radiologists be accessible and available to other healthcare workers in the enterprise, frequent interruptions have negative impact on productivity and well-being. A novel communication app was developed that streamlines communication between technologists and radiologists: RadConnect.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

79

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leiden, Netherlands, 2333 ZA
        • Leiden University Medical Center (LUMC)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Subjects are not patients, but radiologists, technologist, doctor assistants and physician assistants employeed by LUMC. That drive the radiological workflow and frequently raise and answer questions related to the image acquisition.

Description

Inclusion Criteria:

  • Individuals that are employed by LUMC
  • Individuals that are radiologists, radiology fellows, radiology residents, radiology technologists, doctor assistants, physician assistants or other support personnel in the Department of Radiology that raise managing image acquisition related questions.
  • Individuals that consent to participating in the study.
  • Individuals scheduled to work at locations at Sending Extensions, Receiving Extensions and Control Extensions.

Exclusion Criteria:

  • Individuals not able to understand or not willing to sign the informed consent form.
  • Individuals that indicate that they do no comprehend RadConnect and/or its intended use after two educational sessions.
  • Individuals not able to not willing to comply with the intended use of RadConnect.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Crossover
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Test the hypothesis that adoption of RadConnect leads to reduction of phone calls to radiologists.
Time Frame: Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
  • P1 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in Before Phase
  • P2 = Mean number of calls per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase

The primary endpoint will be obtained by testing the hypothesis that P1 > P2 using Wilcoxon's one-tailed test with significance level P < 0.05.

Numbers are continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compare experiences and attitudes of technicians and radiologists towards RadConnect versus phone calls.
Time Frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
  • C1 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in Before Phase
  • C2 = Mean number of calls per working day during regular working hours between Sending Extensions and Control Extensions in After Phase

The first secondary endpoint will be obtained by testing the hypothesis that C1 ≠ C2 using Wilcoxon's two-tailed test with significance level P < 0.05.

Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before (phase 1) and 40 consecutive working days during the after phase(phase 2) of this study.
Measure the characteristics of technician questions raised over phone and through RadConnect.
Time Frame: Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.

• R2 = Mean number of completed RadConnect consultations per working day during regular working hours between Sending Extensions and Receiving Extensions in After Phase

The second secondary endpoint will be obtained by testing the hypothesis that P1 ≠ P2 + R2 using Wilcoxon's two-tailed test with significance level P < 0.05.

Continously measured during each shift of the subjects over a period of 40 consecutive working days during the before phase (phase 1) and 40 consecutive working days during the after phase (phase 2) of this study.
Consolidated opinion usability and experience of RadConnect in itself and in comparison to alternative communication methods.
Time Frame: 1 hour, after completion of the after phase (phase 2 of this study)
The third secondary endpoint will be obtained by aggregating survey responses. In the structured online survey, if more than half of the respondents indicate that they prefer communication over RadConnect to calling, it will be concluded that RadConnect is a viable alternative to calling. If more than half of radiologist respondents indicate that they believe RadConnect helps them avoid interruptions, it will be concluded that RadConnect is a viable alternative to calling that may help reduce radiologist interruptions. The opinions of study participants are captured as Likert scale response and averaged to obtain a consolidated opinion. The consolidated responses are visualized as histograms.
1 hour, after completion of the after phase (phase 2 of this study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hildo Lamb, Prof. Dr., Leiden University Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 29, 2022

Primary Completion (Actual)

July 13, 2023

Study Completion (Actual)

July 13, 2023

Study Registration Dates

First Submitted

September 8, 2022

First Submitted That Met QC Criteria

September 13, 2022

First Posted (Actual)

September 14, 2022

Study Record Updates

Last Update Posted (Actual)

July 21, 2023

Last Update Submitted That Met QC Criteria

July 20, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ICBE-S-000556

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication

Subscribe